Elsevier

The Lancet

Volume 377, Issue 9782, 11–17 June 2011, Pages 2031-2041
The Lancet

Health Policy
Towards an improved investment approach for an effective response to HIV/AIDS

https://doi.org/10.1016/S0140-6736(11)60702-2Get rights and content

Summary

Substantial changes are needed to achieve a more targeted and strategic approach to investment in the response to the HIV/AIDS epidemic that will yield long-term dividends. Until now, advocacy for resources has been done on the basis of a commodity approach that encouraged scaling up of numerous strategies in parallel, irrespective of their relative effects. We propose a strategic investment framework that is intended to support better management of national and international HIV/AIDS responses than exists with the present system. Our framework incorporates major efficiency gains through community mobilisation, synergies between programme elements, and benefits of the extension of antiretroviral therapy for prevention of HIV transmission. It proposes three categories of investment, consisting of six basic programmatic activities, interventions that create an enabling environment to achieve maximum effectiveness, and programmatic efforts in other health and development sectors related to HIV/AIDS. The yearly cost of achievement of universal access to HIV prevention, treatment, care, and support by 2015 is estimated at no less than US$22 billion. Implementation of the new investment framework would avert 12·2 million new HIV infections and 7·4 million deaths from AIDS between 2011 and 2020 compared with continuation of present approaches, and result in 29·4 million life-years gained. The framework is cost effective at $1060 per life-year gained, and the additional investment proposed would be largely offset from savings in treatment costs alone.

Introduction

By 2010, extraordinary amounts of political commitment, social mobilisation, and HIV/AIDS funding had resulted in an unprecedented scale-up of HIV/AIDS prevention, treatment, care, and support, a decline in incidence of new HIV infections in several countries, more than 6·5 million people receiving antiretroviral therapy, and millions of orphans able to receive basic education, health, and social protection.1, 2 Such large-scale investments helped progress towards more tolerant and enabling social environments.3 However, despite these impressive gains, universal access to prevention, treatment, care, and support for HIV/AIDS is not available worldwide,4 and is unlikely to be achieved with the present pace of change and with the present approaches to investment.

Previously set global targets and associated resource needs estimates5, 6 were effective for mobilisation of unprecedented resources and driving of major progress in the HIV/AIDS response, but were based on the prevailing commodity approach that targeted scale-up of discrete interventions rather than overall results, and led in many cases to fragmentation of the response.7, 8

The approach adopted until now has various shortcomings. First, estimates of future coverage of intervention programmes were made on the basis of a large number of ambitious—and often aspirational—targets, which were not met. Second, subsequent revisions shortened the timeframe available to meet targets, making them further out of reach with increasingly unrealistic programmatic and cost assumptions. Third, as the complexities and costs of a public health response to the HIV/AIDS epidemic and the systemic weaknesses that impeded progress became apparent, the commodity approach was not conducive for countries and donors to set priorities as shown by substantial differences in resource allocation for national HIV/AIDS responses between neighbouring countries with equivalent epidemics. Unsystematic prioritisation and investment were allowed to persist9 as interests and stakeholders competed for a proportion of available funding for HIV/AIDS, spreading resources thinly between many objectives.10

New approaches are needed to achieve universal access and the specific targets included in the Joint United Nations Programme on HIV/AIDS (UNAIDS) 2011–15 strategy and the United Nations Secretary General's Report to the General Assembly in June, 2011.4, 11 A change from the commodity approach to a targeted strategic investment programme driven by the latest evidence is needed to produce substantial and lasting effects on the HIV/AIDS epidemic and make the most of investment in the response.

We propose an investment framework to support management of national and international HIV/AIDS responses, encourage transparency in programme objectives and results, and enable decision makers and financiers to galvanise support for effective action. The framework differentiates between basic programme activities that aim to directly reduce HIV transmission, morbidity, and mortality; activities that are necessary to support the effectiveness and efficiency of these programmes (critical enablers); and investments in other sectors that can have a positive effect on HIV outcomes (synergies with development sectors; figure 1). The framework promotes prioritisation of efforts on the basis of a nuanced understanding of country epidemiology and context, and assumes major efficiency gains as delivery of care evolves from facility-based to community-based structures.12

The framework aims to enhance present efforts to make the most of HIV/AIDS responses, including the Global Fund to Fight AIDS, Tuberculosis and Malaria's new approach to fund countries on the basis of national strategy applications13 rather than discrete projects.14 Equally, the framework supports improved planning for resource allocation in the largest bilateral HIV/AIDS programme, the US President's Emergency Plan for AIDS Relief (PEPFAR), which has a new and explicit focus on increased country ownership.15 The framework will encourage countries to make the most of their programmatic responses to the epidemic through careful targeting and selection of the most effective interventions.

In this Health Policy, we present the investment framework and apply it in a costing exercise undertaken to estimate the resources needed to implement a global HIV/AIDS response in the next decade.

Section snippets

Outline

The approach previously taken by UNAIDS estimated total resource needs on the basis of unit costs and coverage targets for all commonly undertaken prevention, treatment, care, and support activities for HIV/AIDS.5, 6 Infections and deaths averted were modelled on the basis of the estimated effect of each of these interventions. The aids 2031 project16 subsequently used much the same model to develop various scenarios for global HIV/AIDS responses; in their most optimistic scenario all component

Resources needed for the new investment framework

Our modelling exercise estimates resource needs and returns on investment for 139 low-income and middle-income countries. The resource needs estimate is the cost of increasing from present rates of coverage in 2011 to achieve universal access by 2015 and maintain it thereafter. For the baseline scenario, we assumed constant coverage at about present funding rates72 and approaches except for the reductions in antiretroviral drug costs which we assumed would decline over time at the same rate in

Investments in HIV/AIDS and returns

Table 2 and figure 3 show the financing needed for the full rollout of this new investment framework for 2011–20. Resource needs increase from present rates of about US$16 billion to peak at $22 billion in 2015 when universal coverage will be achieved. Resource needs will then decline after 2015 for three main reasons: first, coverage will have reached target rates for the interventions included in the new framework and will be kept stable at these rates; second, efficiency gains will continue

Development synergies

Our estimate of financing needs to achieve strong synergies with development sectors was based on costs of gender-based violence programmes, a number of health-sector elements, youth in schools programmes, workplace education, and provision for children orphaned by HIV/AIDS (see webappendix pp 24–25). The total cost was $3·6 billion for 2011, increasing to about $5·4 billion by 2020 (table 2). While this framework does not intend to be prescriptive about spending to support sectoral synergies,

Discussion

The United Nations high-level meeting on HIV/AIDS in June, 2011, provides an unrivalled opportunity to take stock of the striking progress made in the response to HIV/AIDS since the United Nations General Assembly Special Session on HIV/AIDS 10 years ago.78 The meeting will allow gaps in the response to be identified and generate high-level political commitment for a substantial shift in the HIV/AIDS response to ensure programme improvement. We propose a new investment framework to guide

References (88)

  • AIDS 2011: progress, ownership and shared accountability

    (2011)
  • Children and AIDS: fifth stocktaking report, 2010

    (2010)
  • Report on the global AIDS epidemic

    (2010)
  • Report of the Secretary-General: uniting for universal access: towards zero new HIV infections, zero discrimination and zero AIDS-related deaths

  • B Schwartländer et al.

    AIDS. Resource needs for HIV/AIDS

    Science

    (2001)
  • What countries need. Investments needed for 2010 targets

    (2009)
  • B Samb et al.

    An assessment of interactions between global health initiatives and country health systems

    Lancet

    (2009)
  • Report on the global AIDS epidemic 2008

    (2008)
  • V Hester et al.

    Draft working paper: assessing costing and prioritization in national AIDS strategic plans. Results for development institute/AIDS 2031

  • UNAIDS 2011–2015 strategy: getting to zero

    (2011)
  • The Global Fund 2010. Innovation and impact

  • Health systems funding platform pilot. Final decision points for the 22nd board meeting

  • National strategy aplications first learning wave. Final decision points for the 18th board meeting

  • PEPFAR: making smart investments to increase impact and efficiency and save more lives

  • Costs and choices: financing the long-term fight against AIDS

  • S Reza-Paul et al.

    Declines in risk behaviour and sexually transmitted infection prevalence following a community-led HIV preventive intervention among female sex workers in Mysore, India

    AIDS

    (2008)
  • M Sidibe et al.

    People, passion & politics: looking back and moving forward in the governance of the AIDS response

    Glob Health Gov

    (2010)
  • R Atun et al.

    Integration of targeted health interventions into health systems: a conceptual framework for analysis

    Health Policy Plan

    (2010)
  • CG Victora et al.

    Evidence-based public health: moving beyond randomized trials

    Am J Public Health

    (2004)
  • NS Padian et al.

    Weighing the gold in the gold standard: challenges in HIV prevention research

    AIDS

    (2010)
  • Padian NS, McCoy SI, Abdool Karim S, et al. HIV prevention transformed: the new prevention research agenda. Lancet (in...
  • LA Bollinger

    How can we calculate the “E” in “CEA”?

    AIDS

    (2008)
  • LM Mofenson

    Prevention in neglected subpopulations: prevention of mother-to-child transmission of HIV infection

    Clin Infect Dis

    (2010)
  • B Auvert et al.

    Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial

    PLoS Med

    (2005)
  • Redefining AIDS in Asia: crafting an effective response. Report of the Commission on AIDS in Asia

    (2008)
  • Kenya HIV prevention response and modes of transmission analysis

    (2009)
  • New HIV infections by mode of transmission in West Africa: a multi-country analysis

    (2010)
  • Harm reduction: evidence, impacts and challenges

  • WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users

    (2009)
  • EF Long et al.

    Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia

    AIDS

    (2006)
  • TB Hallett et al.

    Declines in HIV prevalence can be associated with changing sexual behaviour in Uganda, urban Kenya, Zimbabwe, and urban Haiti

    Sex Transm Infect

    (2006)
  • RJ DiClemente et al.

    A review of STD/HIV preventive interventions for adolescents: sustaining effects using an ecological approach

    J Pediatr Psychol

    (2007)
  • S Gregson et al.

    HIV decline associated with behavior change in eastern Zimbabwe

    Science

    (2006)
  • DT Halperin et al.

    A surprising prevention success: why did the HIV epidemic decline in Zimbabwe?

    PLoS Med

    (2011)
  • Cited by (373)

    • Pharmaceutical regulatory requirements of nonregulated markets

      2022, Regulatory Affairs in the Pharmaceutical Industry
    View all citing articles on Scopus

    Members listed at end of paper

    View full text